Food and Drug Regulations (C.R.C., c. 870)
Full Document:
- HTMLFull Document: Food and Drug Regulations (Accessibility Buttons available) |
- XMLFull Document: Food and Drug Regulations [4113 KB] |
- PDFFull Document: Food and Drug Regulations [5999 KB]
Regulations are current to 2021-02-15 and last amended on 2020-09-28. Previous Versions
SCHEDULE(Sections G.01.001 and G.01.002, subsections G.01.005(1) and G.02.058(1), section G.02.073, subsection G.03.001(3), paragraph G.03.006(a), section G.03.007 and subsection G.05.001(4))
PART I
- Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, excluding those substances set out in item 1 of Part I of the schedule to Part J but including:
- amphetamine (α-methylbenzeneethanamine)
- methamphetamine (N,α-dimethylbenzeneethanamine)
- Benzphetamine (N-benzyl-N,α-dimethylbenzeneethanamine)
- Methylphenidate (methyl 2-phenyl-2-(piperidin-2-yl)acetate), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including:
- Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate)
- Isopropylphenidate (isopropyl 2-phenyl-2-(piperidin-2-yl)acetate)
- Propylphenidate (propyl 2-phenyl-2-(piperidin-2-yl)acetate)
- 3,4-Dichloromethylphenidate (methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate)
- 4-Methylmethylphenidate (methyl 2-(4-methylphenyl)-2-(piperidin-2-yl)acetate)
- 4-Fluoromethylphenidate (methyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate)
- Methylnaphthidate (methyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate)
- Ethylnaphthidate (ethyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate)
- Methaqualone (2-methyl-3-(2-methylphenyl)-4(3H)quinazolinone) and any salt thereof
- Phendimetrazine (d-3,4-dimethyl-2-phenylmorpholine) and any salt thereof
- Phenmetrazine (3-methyl-2-phenylmorpholine) and any salt thereof
- Pentobarbital (5-ethyl-5-(1-methylbutyl)barbituric acid)
- Secobarbital (5-allyl-5-(1-methylbutyl)barbituric acid)
- 4-hydroxybutanoic acid (GHB) and any salt thereof
- Aminorex (5-phenyl-4,5-dihydro-1,3-oxazol-2-amine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including
- 4-Methylaminorex (4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine)
- 4,4’-Dimethylaminorex (4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)
- Fenetylline (d,l-3,7-dihydro-1,3-dimethyl-7-(2-[(1-methyl-2-phenethyl)amino]ethyl)-1H-purine-2,6-dione) and any salt thereof
- Glutethimide (2-ethyl-2-phenylglutarimide)
- Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine), its salts, derivatives and isomers and salts of derivatives and isomers
- Mecloqualone (2-methyl-3-(2-chlorophenyl)-4(3H)-quinazolinone) and any salt thereof
- Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof
- Pemoline (2-amino-5-phenyl-oxazolin-4-one) and any salt thereof
- Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof
- Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof
PART II
- Barbiturates, their salts and derivatives, excluding the substances set out in items 6 and 7 of Part I of this schedule, as well as barbituric acid (2,4,6(1H,3H,5H)-pyrimidinetrione) and its salts and 1,3-dimethylbarbituric acid (1,3-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione) and its salts, but including
- Allobarbital (5,5-diallylbarbituric acid)
- Alphenal (5-allyl-5-phenylbarbituric acid)
- Amobarbital (5-ethyl-5-(3-methylbutyl)barbituric acid)
- Aprobarbital (5-allyl-5-isopropylbarbituric acid)
- Barbital (5,5-diethylbarbituric acid)
- [Repealed, SOR/2017-12, s. 1]
- Butabarbital (5-sec-butyl-5-ethylbarbituric acid)
- Butalbital (5-allyl-5-isobutylbarbituric acid)
- Butallylonal (5-(2-bromoallyl)-5-sec-butylbarbituric acid)
- Butethal (5-butyl-5-ethylbarbituric acid)
- Cyclobarbital (5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid)
- Cyclopal (5-allyl-5-(2-cyclopenten-1-yl)barbituric acid)
- Heptabarbital (5-(1-cyclohepten-1-yl)-5-ethylbarbituric acid)
- Hexethal (5-ethyl-5-hexylbarbituric acid)
- Hexobarbital (5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid)
- Mephobarbital (5-ethyl-1-methyl-5-phenylbarbituric acid)
- Methabarbital (5,5-diethyl-1-methylbarbituric acid)
- Methylphenobarbital (5-ethyl-1-methyl-5-phenylbarbituric acid)
- Propallylonal (5-(2-bromoallyl)-5-isopropyl-barbituric acid)
- Phenobarbital (5-ethyl-5-phenylbarbituric acid)
- Probarbital (5-ethyl-5-isopropylbarbituric acid)
- Phenylmethylbarbituric Acid (5-methyl-5-phenylbarbituric acid)
- Sigmodal(5-(2-bromoallyl)-5-(1-methylbutyl)- barbituric acid)
- Talbutal (5-allyl-5-sec-butylbarbituric acid)
- Vinbarbital (5-ethyl-5-(1-methyl-1-butenyl)barbituric acid)
- Vinylbital (5-(1-methylbutyl)-5-vinylbarbituric acid)
- Thiobarbiturates, their salts and derivatives, including:
- Thialbarbital (5-allyl-5-(2-cyclohexen-1-yl)-2-thiobarbituric acid)
- Thiamylal (5-allyl-5-(1-methylbutyl)-2-thiobarbituric acid)
- Thiobarbituric Acid (2-thiobarbituric acid)
- Thiopental(5-ethyl-5-(1-methylbutyl)-2- thiobarbituric acid)
- Chlorphentermine (1-(p-chlorophenyl)-2-methyl-2-aminopropane) and any salt thereof
- Diethylpropion (2-(diethylamino)propiophenone) and any salt thereof
- Phentermine (α,α-dimethylbenzeneethanamine) and any salt thereof
- Butorphanol (1-N-cyclobutylmethyl-3,14-dihydroxymorphinan) and its salts
- Nalbuphine (N-cyclobutylmethyl-4,5-epoxy-morphinan-3,6,14-triol) and any salt thereof
- Pyrovalerone (4′-methyl-2-(1-pyrrolidinyl)valerophenone) and any salt thereof
PART III
- Anabolic steroids and their derivatives, including:
- Androisoxazole (17ß-hydroxy-17α-methylandrostano[3,2-c]isoxazole)
- Androstanolone (17ß-hydroxy-5α-androstan-3-one)
- Androstenediol (androst-5-ene-3ß,17ß-diol)
- Bolandiol (estr-4-ene-3b,17ß-diol)
- Bolasterone (17ß-hydroxy-7α,17-dimethylandrost-4-en-3-one)
- Bolazine (17ß-hydroxy-2α-methyl-5α-androstan-3-one azine)
- Boldenone (17ß-hydroxyandrosta-1,4-dien-3-one)
- Bolenol (19-nor-17α-pregn-5-en-17-ol)
- Calusterone (17ß-hydroxy-7b,17-dimethylandrost-4-en-3-one)
- Clostebol (4-chloro-17ß-hydroxyandrost-4-en-3-one)
- Drostanolone (17ß-hydroxy-2α-methyl-5α-androstan-3-one)
- Enestebol (4,17ß-dihydroxy-17-methylandrosta-1,4-dien-3-one)
- Epitiostanol (2α, 3α-epithio-5α-androstan-17ß-ol)
- Ethylestrenol (19-nor-17α-pregn-4-en-17-ol)
- 4-Hydroxy-19-nor testosterone
- Fluoxymesterone (9-fluoro-11ß,17ß-dihydroxy — 17-methylandrost-4-en-3-one)
- Formebolone (11α,17ß-dihydroxy-17-methyl-3-oxoandrosta-1,4-dien-2-carboxaldehyde)
- Furazabol (17-methyl-5α-androstano[2,3-c]furazan-17ß-ol)
- Mebolazine (17ß-hydroxy-2α,17-dimethyl-5α-androstan-3-one azine)
- Mesabolone (17ß-[(1-methoxycyclohexyl)oxy]-5α-androst-1-en-3-one)
- Mesterolone (17ß-hydroxy-1α-methyl-5α-androstan-3-one)
- Metandienone (17ß-hydroxy-17-methylandrosta-1,4-dien-3-one)
- Metenolone (17ß-hydroxy-1-methyl-5α-androst-1-en-3-one)
- Methandriol (17α-methylandrost-5-ene-3ß,17ß-diol)
- Methyltestosterone (17ß-hydroxy-17-methyl-androst-4-en-3-one)
- Metribolone (17ß-hydroxy-17-methylestra-4,9,11-trien-3-one)
- Mibolerone (17ß-hydroxy-7α,17-dimethylestr-4-en-3-one)
- Nandrolone (17ß-hydroxyestr-4-en-3-one)
- Norboletone (13-ethyl-17ß-hydroxy-18,19-dinorpregn-4-en-3-one)
- Norclostebol (4-chloro-17ß-hydroxyestr-4-en-3-one)
- Norethandrolone (17α-ethyl-17ß-hydroxyestr-4-en-3-one)
- Oxabolone (4,17ß-dihydroxyestr-4-en-3-one)
- Oxandrolone (17ß-hydroxy-17-methyl-2-oxa-5α-androstan-3-one)
- Oxymesterone (4,17ß-dihydroxy-17-methylandrost-4-en-3-one)
- Oxymetholone (17ß-hydroxy-2-(hydroxymethylene)-17-methyl-5α-androstan-3-one)
- Prasterone (3ß-hydroxyandrost-5-en-17-one)
- Quinbolone (17ß-(1-cyclopenten-1-yloxy)androsta-1,4-dien-3-one)
- Stanozolol (17ß-hydroxy-17-methyl-5α-androstano[3,2-c]pyrazole)
- Stenbolone (17ß-hydroxy-2-methyl-5α-androst-1-en-3-one)
- Testosterone (17ß-hydroxyandrost-4-en-3-one)
- Tibolone ((7α,17α)-17-hydroxy-7-methyl-19-norpregn-5(10)en-20-yn-3-one)
- Tiomesterone (1α,7α-bis(acetylthio)-17ß-hydroxy-17-methylandrost-4-en-3-one)
- Trenbolone (17ß-hydroxyestra-4,9,11-trien-3-one)
- Zeranol (3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1-one)
- SOR/78-427, s. 10
- SOR/79-753, s. 1
- SOR/81-84, s. 1
- SOR/85-550, s. 14(F)
- SOR/86-678, s. 1
- SOR/89-381, s. 1
- SOR/92-386, s. 3
- SOR/97-228, s. 21
- SOR/99-425, s. 1
- SOR/2003-34, ss. 2, 3
- SOR/2003-413, s. 2
- SOR/2015-210, s. 1
- SOR/2016-106, s. 1
- SOR/2017-12, ss. 1, 2(E)
- SOR/2017-43, s. 1
- SOR/2017-250, s. 1
- SOR/2019-171, s. 21
- Date modified: